Immunopathogenesis of cholestatic autoimmune liver diseases

被引:14
|
作者
Medina, J
Jones, EA
García-Monzón, C
Moreno-Otero, R
机构
[1] Univ Autonoma Madrid, Hosp Princesa, Liver Unit, Madrid 28006, Spain
[2] Novartis Pharma AG, Preclin Safety Dept, Basel, Switzerland
[3] Univ Amsterdam, Acad Med Ctr, Dept Gastrointestinal & Liver Dis, NL-1105 AZ Amsterdam, Netherlands
关键词
autoantibodies; autoantigens; cholestatic; epitopes; liver autoimmunity;
D O I
10.1046/j.1365-2362.2001.00765.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary biliary cirrhosis and primary sclerosing cholangitis are well recognized chronic cholestatic liver diseases that are considered to have an autoimmune basis. Recent progress in the study of autoimmune liver diseases has improved the recognition and characterization of these conditions. An important component of this progress has been the identification of liver disease-associated autoantibodies and their respective target antigens, and the development of specific assays for these autoantibodies. In addition, some nonhumoral immunological findings imply an involvement of specific immunopathogenic mechanisms in the development of these conditions. Furthermore, immunogenetic factors associated with increased susceptibility to some of these diseases have been identified. This article reviews the most relevant information relating to the postulated autoimmune pathogenesis of these diseases, with special emphasis on their associated humoral and cellular immunological abnormalities and immunopathogenetic factors. Some of the remaining important unresolved issues relating to the pathogenesis of these diseases, that need to be addressed in further research, are highlighted.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [1] Autoimmune mediated cholestatic Liver Diseases
    Mayer, Lena Sophie
    Kaeser, Rafael
    Boettler, Tobias
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (05) : 296 - 305
  • [2] Histology of autoimmune cholestatic liver diseases
    Desmet, VJ
    [J]. CHOLESTATIC LIVER DISEASES: THERAPEUTIC OPTIONS AND PERSPECTIVES: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 136 : 47 - 55
  • [3] Histological classification of autoimmune cholestatic liver diseases
    Hübscher, SG
    [J]. IMMUNOLOGY & LIVER, 2000, 114 : 223 - 243
  • [4] PREVALENCE OF SYSTEMIC AUTOIMMUNE DISEASES IN PATIENTS WITH AUTOIMMUNE HEPATITIS AND CHOLESTATIC LIVER DISEASES
    Lledo, Gema-Maria
    Llovet, Laura Patricia
    Oliver, Lydia Sastre
    Espinosa, Gerard
    Londono, Maria Carlota
    [J]. HEPATOLOGY, 2020, 72 : 756A - 756A
  • [5] Cholestatic Autoimmune Diseases of the Liver: Noninvasive Variceal Prediction
    Lorenz, Judith
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (07):
  • [6] Serum transferrin isoforms in autoimmune cholestatic liver diseases
    Chrostek, L.
    Bauer, A.
    Gruszewska, E.
    Cylwik, B.
    [J]. CLINICA CHIMICA ACTA, 2022, 530 : S192 - S192
  • [7] Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases
    Dalekos, George N.
    Gatselis, Nikolaos K.
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (04) : 197 - 211
  • [8] Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases
    George N. Dalekos
    Nikolaos K. Gatselis
    [J]. Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 197 - 211
  • [9] IMMUNOPATHOGENESIS OF AUTOIMMUNE HEPATOBILIARY DISEASES
    FREILICH, BL
    HU, KQ
    VIERLING, JM
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 1994, 10 (03) : 257 - 268
  • [10] Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
    Nicola Pugliese
    Ivan Arcari
    Alessio Aghemo
    Andrea G Lania
    Ana Lleo
    Gherardo Mazziotti
    [J]. World Journal of Gastroenterology, 2022, (14) : 1430 - 1443